Bio-Reference Labs (BRLI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio-Reference Labs (BRLI)

BRLI 4.700

-44.0%

Dec 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dick Jaffe who wrote (203)	10/26/1997 10:52:00 AM
From: steve host	Read Replies (1) of 223

Agree 100% I plan on doubling my position at this level. This company is doing better than it ever did in both revenues and profits yet it use to sell for over $6 - only a matter of time. I am curious about the division that they sold - the press release said it accounted for only 8% of its revenues , but it did not say what % of net profits it accounted for. I would be interested in that figure. According to the annual report from 1996 this unit had one of the highest growth rates per patient from $98 per patient in 1995 to $150 per patient in 1996 - I am curious why they would sell this unless the income from the other units have picked up similarly to make up for this revenue. If anyone calls management - please inquire - I will see if I have time this week. In any event the cash in the bank now after this deal should be around $1.20 for a $1.60 stock this is amazing, not to mention a book at cost of at least $2.75 but probably a lot more based on what they sold Gencare for. As far as Im concerned I hope it hangs here for a little so I can further establish a position.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next